BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 124742)

  • 1. Control of normal differentiation of myeloid leukemic cells. VI. Inhibition of cell multiplication and the formation of macrophages.
    Lotem J; Sachs L
    J Cell Physiol; 1975 Jun; 85(3):587-94. PubMed ID: 124742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of normal differentiation of myeloid leukemic cells. VIII. Induction of differentiation to mature granulocytes in mass culture.
    Fibach E; Sachs L
    J Cell Physiol; 1975 Oct; 86(2 Pt 1):221-30. PubMed ID: 1194362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of differentiation of Rauscher virus-induced mouse myeloid leukemia cells with a factor(s) in ascitic fluid and inhibitors of nucleic acid and protein syntheses.
    Sugiyama K; Hozumi M; Okabe J
    Cancer Res; 1979 Mar; 39(3):1056-62. PubMed ID: 427746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of normal differentiation of myeloid leukemic cells. XI. Induction of a specific requirement for cell viability and growth during the differentiation of myeloid leukemic cells.
    Fibach E; Sachs L
    J Cell Physiol; 1976 Oct; 89(2):259-66. PubMed ID: 972167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in surface membrane ecto-ATPase and ecto-AMPase in normal and malignant cells. I. Decrease in ecto-ATPase in myeloid leukemic cells and the independent regulation of ecto-ATPase and ecto-AMPase.
    Weiss B; Sachs L
    J Cell Physiol; 1977 Nov; 93(2):183-8. PubMed ID: 145444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different blocks in the differentiation of myeloid leukemic cells.
    Lotem J; Sachs L
    Proc Natl Acad Sci U S A; 1974 Sep; 71(9):3507-11. PubMed ID: 4530318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential pre-screening for therapeutic agents that induce differentiation in human myeloid leukemia cells.
    Lotem J; Sachs L
    Int J Cancer; 1980 May; 25(5):561-4. PubMed ID: 6929273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of normal differentiation of myeloid leukemic cells. XIII. Inducibility for some stages of differentiation by dimethylsulfoxide and its disassociation from inducibility by MGI.
    Maeda S; Sachs L
    J Cell Physiol; 1978 Feb; 94(2):181-5. PubMed ID: 304449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tunicamycin on production by mouse fibroblast L929 cells of the factor-stimulating differentiation of mouse myeloid leukemic cells and the colony-stimulating factor.
    Yamamoto Y; Tomida M; Hozumi M; Ayusawa D; Seno T; Tamura G
    Cancer Res; 1981 Jun; 41(6):2534-9. PubMed ID: 6972252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of normal differentiation of myeloid leukemic cells. X. Glucose utilization, cellular ATP and associated membrane changes in D+ and D- cells.
    Vlodavsky I; Fibach E; Sachs L
    J Cell Physiol; 1975 Dec; 87(2):167-77. PubMed ID: 1061711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The study of human myeloid differentiation using bromodeoxyuridine (BrdU).
    Keoffler HP; Yen J; Carlson J
    J Cell Physiol; 1983 Jul; 116(1):111-7. PubMed ID: 6574132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of normal differentiation of myeloid leukemic cells. IV. Induction of differentiation by serum from endotoxin treated mice.
    Fibach E; Sachs L
    J Cell Physiol; 1974 Apr; 83(2):177-85. PubMed ID: 4595662
    [No Abstract]   [Full Text] [Related]  

  • 13. Control of Fc and C3 receptors on myeloid leukemic cells.
    Lotem J; Sachs L
    J Immunol; 1976 Aug; 117(2):580-6. PubMed ID: 950462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface changes in HeLa cells as an indication of cell cycle events.
    Lundgren E; Roos G
    Cancer Res; 1976 Nov; 36(11 Pt 1):4044-51. PubMed ID: 61800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production by undifferentiated myeloid leukemia cells of a novel growth-inhibitory factor(s) for partially differentiated myeloid leukemic cells.
    Kasukabe T; Okabe-Kado J; Honma Y; Hozumi M
    Jpn J Cancer Res; 1987 Sep; 78(9):921-31. PubMed ID: 3117748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of lysozyme induction in the differentiation of myeloid leukemic cells.
    Krystosek A; Sachs L
    Cell; 1976 Dec; 9(4 PT 2):675-84. PubMed ID: 1017012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of differentiation of mouse myeloid leukemic cells and induction of interferon in the cells by double-stranded polyribonucleotides.
    Yamamoto Y; Tomida M; Hozumi M
    Cancer Res; 1979 Oct; 39(10):4170-4. PubMed ID: 289438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of factors stimulating differentiation of mouse myeloid leukemia cells from a Yoshida sarcoma cell line cultured in serum-free medium.
    Hozumi M; Umezawa T; Takenaga K; Ohno T; Shikita M; Yamane I
    Cancer Res; 1979 Dec; 39(12):5127-31. PubMed ID: 315274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production by mouse spleen cells of factors stimulating differentiation of mouse myeloid leukemic cells that differ from the colony-stimulating factor.
    Yamamoto Y; Tomida M; Hozumi M
    Cancer Res; 1980 Dec; 40(12):4804-9. PubMed ID: 6159972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of normal myeloblast viability and multiplication without blocking differentiation by type C RNA virus from myeloid leukemic cells.
    Liebermann D; Sachs L
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3353-7. PubMed ID: 226969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.